Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Sandelin

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
A randomised study of axillary drainage and pectoral fascia preservation after mastectomy for breast cancerK Dalberg, H Johansson, T Signomklao, et al.
Human Molecular Genetics|April 1, 1993
Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) geneK Kas, G Weber, J Merregaert, et al.
Hormone Research|January 1, 1997
Multiple endocrine neoplasia type 1 and the search for the genetic triggerF Farnebo, J Järhult, L O Farnebo, et al.
Human Molecular Genetics|October 1, 1994
The phospholipase C beta 3 gene located in the MEN1 region shows loss of expression in endocrine tumoursG Weber, E Friedman, S Grimmond, et al.
World Journal of Surgery|December 5, 1998
Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid diseaseF Farnebo, G Auer, L O Farnebo, et al.
British Journal of Cancer|February 2, 2013
Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised studyL Holmberg, Y N S Wong, L Tabár, et al.
Endocrine-Related Cancer|July 20, 2007
Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classificationC C Juhlin, A Villablanca, K Sandelin, et al.
Human Genetics|March 1, 1997
Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidismF Farnebo, B T Teh, C Dotzenrath, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2006
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trialA Ringberg, H Nordgren, S Thorstensson, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
Alterations of the MEN1 gene in sporadic parathyroid tumorsF Farnebo, B T Teh, S Kytölä, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
A randomised study of axillary drainage and pectoral fascia preservation after mastectomy for breast cancerK Dalberg, H Johansson, T Signomklao, et al.
Human Molecular Genetics|April 1, 1993
Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) geneK Kas, G Weber, J Merregaert, et al.
Hormone Research|January 1, 1997
Multiple endocrine neoplasia type 1 and the search for the genetic triggerF Farnebo, J Järhult, L O Farnebo, et al.
Human Molecular Genetics|October 1, 1994
The phospholipase C beta 3 gene located in the MEN1 region shows loss of expression in endocrine tumoursG Weber, E Friedman, S Grimmond, et al.
World Journal of Surgery|December 5, 1998
Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid diseaseF Farnebo, G Auer, L O Farnebo, et al.
British Journal of Cancer|February 2, 2013
Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised studyL Holmberg, Y N S Wong, L Tabár, et al.
Endocrine-Related Cancer|July 20, 2007
Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classificationC C Juhlin, A Villablanca, K Sandelin, et al.
Human Genetics|March 1, 1997
Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidismF Farnebo, B T Teh, C Dotzenrath, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2006
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trialA Ringberg, H Nordgren, S Thorstensson, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
Alterations of the MEN1 gene in sporadic parathyroid tumorsF Farnebo, B T Teh, S Kytölä, et al.
Pageof 7